|
|
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2877-2886.
Prepublished online as a Blood First Edition Paper on December 21, 2004; DOI 10.1182/blood-2004-07-2505.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
Markus Kleinewietfeld,
Fabiola Puentes,
Giovanna Borsellino,
Luca Battistini,
Olaf Rötzschke, and
Kirsten Falk
From the Max-Delbrück-Center for Molecular Medicine, Berlin, Germany; and Laboratory of Neuroimmunology, Santa Lucia Foundation, Rome, Italy.
Regulatory CD25+CD4+ T cells (Treg cells) are a central element of peripheral tolerance. Little is known, however, about phenotypic and functional characteristics of these cells with regard to memory. In this study we show that the chemokine receptor CCR6 is expressed on a distinct subset of mouse Treg cells. Similar to their CD25- counterparts, CCR6+ Treg cells exhibit markers of activation, memory, and expansion that are indicative for an effector-memory function. They are memory-like cells, generated in vivo from CCR6-CD25+ T cells after the encounter of antigen. As conventional CD25- effector-memory T cells, they have a high turnover rate and, in contrast to CCR6- Treg cells, they respond rapidly to restimulation in vitro with up-regulation of interleukin 10. CCR6+ Treg cells are enriched in the peripheral blood and accumulate in the central nervous system after induction of experimental autoimmune encephalomyelitis (EAE). This subset therefore seems to represent a population of regulatory effector-memory T cells (TREM), destined to control potentially destructive immune responses directly in inflamed tissues. Importantly, these cells are also present in humans. Here the expression of CCR6 fully cosegregates with CD45RO, an established marker of human memory T cells.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
H. Kvakan, M. Kleinewietfeld, F. Qadri, J.-K. Park, R. Fischer, I. Schwarz, H.-P. Rahn, R. Plehm, M. Wellner, S. Elitok, et al.
Regulatory T Cells Ameliorate Angiotensin II-Induced Cardiac Damage
Circulation,
June 9, 2009;
119(22):
2904 - 2912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Rotzschke, G. Borsellino, L. Battistini, K. Falk, and M. Kleinewietfeld
In vivo-activated CD103+ Foxp3+ Tregs: of men and mice
Blood,
February 26, 2009;
113(9):
2119 - 2120.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. B. Tan, P. S. Goedegebuure, B. A. Belt, B. Flaherty, N. Sankpal, W. E. Gillanders, T. J. Eberlein, C.-S. Hsieh, and D. C. Linehan
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
J. Immunol.,
February 1, 2009;
182(3):
1746 - 1755.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kleinewietfeld, M. Starke, D. Di Mitri, G. Borsellino, L. Battistini, O. Rotzschke, and K. Falk
CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells
Blood,
January 22, 2009;
113(4):
827 - 836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Muthuswamy, J. Urban, J.-J. Lee, T. A. Reinhart, D. Bartlett, and P. Kalinski
Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation
Cancer Res.,
July 15, 2008;
68(14):
5972 - 5978.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. R.N. Baumforth, A. Birgersdotter, G. M. Reynolds, W. Wei, G. Kapatai, J. R. Flavell, E. Kalk, K. Piper, S. Lee, L. Machado, et al.
Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells
Am. J. Pathol.,
July 1, 2008;
173(1):
195 - 204.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Lochner, L. Peduto, M. Cherrier, S. Sawa, F. Langa, R. Varona, D. Riethmacher, M. Si-Tahar, J. P. Di Santo, and G. Eberl
In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ ROR{gamma}t+ T cells
J. Exp. Med.,
June 9, 2008;
205(6):
1381 - 1393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Chen, J. J. Subleski, H. Kopf, O. M. Z. Howard, D. N. Mannel, and J. J. Oppenheim
Cutting Edge: Expression of TNFR2 Defines a Maximally Suppressive Subset of Mouse CD4+CD25+FoxP3+ T Regulatory Cells: Applicability to Tumor-Infiltrating T Regulatory Cells
J. Immunol.,
May 15, 2008;
180(10):
6467 - 6471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kleinewietfeld, D. DiMitri, A. Sternjak, A. Diamantini, G. Borsellino, L. Battistini, O. Rotzschke, and K. Falk
Hydrolysis of extracellular ATP by CD39+ Treg cells: context matters!
Blood,
January 15, 2008;
111(2):
965 - 966.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Singh, H. H. Zhang, J. F. Foley, M. N. Hedrick, and J. M. Farber
Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6
J. Immunol.,
January 1, 2008;
180(1):
214 - 221.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tritt, E. Sgouroudis, E. d'Hennezel, A. Albanese, and C. A. Piccirillo
Functional Waning of Naturally Occurring CD4+ Regulatory T-Cells Contributes to the Onset of Autoimmune Diabetes
Diabetes,
January 1, 2008;
57(1):
113 - 123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hirota, H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, et al.
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model
J. Exp. Med.,
November 26, 2007;
204(12):
2803 - 2812.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Facco, I. Baesso, M. Miorin, M. Bortoli, A. Cabrelle, E. Boscaro, C. Gurrieri, L. Trentin, R. Zambello, F. Calabrese, et al.
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis
J. Leukoc. Biol.,
October 1, 2007;
82(4):
946 - 955.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Behrens, A. Himsel, S. Rehart, J. Stanczyk, B. Beutel, S. Y Zimmermann, U. Koehl, B. Moller, S. Gay, J. P Kaltwasser, et al.
Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis
Ann Rheum Dis,
September 1, 2007;
66(9):
1151 - 1156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Borsellino, M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Hopner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al.
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression
Blood,
August 15, 2007;
110(4):
1225 - 1232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Nummer, E. Suri-Payer, H. Schmitz-Winnenthal, A. Bonertz, L. Galindo, D. Antolovich, M. Koch, M. Buchler, J. Weitz, V. Schirrmacher, et al.
Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma
J Natl Cancer Inst,
August 1, 2007;
99(15):
1188 - 1199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Haas, B. Fritzsching, P. Trubswetter, M. Korporal, L. Milkova, B. Fritz, D. Vobis, P. H. Krammer, E. Suri-Payer, and B. Wildemann
Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis
J. Immunol.,
July 15, 2007;
179(2):
1322 - 1330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Lecureuil, B. Combadiere, E. Mazoyer, O. Bonduelle, A. Samri, B. Autran, P. Debre, and C. Combadiere
Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patients
Blood,
May 1, 2007;
109(9):
3649 - 3657.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Baatar, P. Olkhanud, K. Sumitomo, D. Taub, R. Gress, and A. Biragyn
Human Peripheral Blood T Regulatory Cells (Tregs), Functionally Primed CCR4+ Tregs and Unprimed CCR4- Tregs, Regulate Effector T Cells Using FasL
J. Immunol.,
April 15, 2007;
178(8):
4891 - 4900.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Lee, S. G. Kang, and C. H. Kim
FoxP3+ T Cells Undergo Conventional First Switch to Lymphoid Tissue Homing Receptors in Thymus but Accelerated Second Switch to Nonlymphoid Tissue Homing Receptors in Secondary Lymphoid Tissues
J. Immunol.,
January 1, 2007;
178(1):
301 - 311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Fritzsching, N. Oberle, E. Pauly, R. Geffers, J. Buer, J. Poschl, P. Krammer, O. Linderkamp, and E. Suri-Payer
Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death
Blood,
November 15, 2006;
108(10):
3371 - 3378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Yurchenko, M. Tritt, V. Hay, E. M. Shevach, Y. Belkaid, and C. A. Piccirillo
CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence
J. Exp. Med.,
October 30, 2006;
203(11):
2451 - 2460.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hirahara, L. Liu, R. A. Clark, K.-i. Yamanaka, R. C. Fuhlbrigge, and T. S. Kupper
The Majority of Human Peripheral Blood CD4+CD25highFoxp3+ Regulatory T Cells Bear Functional Skin-Homing Receptors
J. Immunol.,
October 1, 2006;
177(7):
4488 - 4494.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tischner, A. Weishaupt, J. v. d. Brandt, N. Muller, N. Beyersdorf, C. W. Ip, K. V. Toyka, T. Hunig, R. Gold, T. Kerkau, et al.
Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis
Brain,
October 1, 2006;
129(10):
2635 - 2647.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.-A. Gross, P. Chappert, M. Leboeuf, V. Monteilhet, L. Van Wittenberghe, O. Danos, and J. Davoust
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products
Blood,
September 15, 2006;
108(6):
1841 - 1848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cassan, E. Piaggio, J. P. Zappulla, L. T. Mars, N. Couturier, F. Bucciarelli, S. Desbois, J. Bauer, D. Gonzalez-Dunia, and R. S. Liblau
Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells
J. Immunol.,
August 1, 2006;
177(3):
1552 - 1560.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. W. Lim, H. E. Broxmeyer, and C. H. Kim
Regulation of Trafficking Receptor Expression in Human Forkhead Box P3+ Regulatory T Cells
J. Immunol.,
July 15, 2006;
177(2):
840 - 851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Wei, I. Kryczek, and W. Zou
Regulatory T-cell compartmentalization and trafficking
Blood,
July 15, 2006;
108(2):
426 - 431.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Stenstad, A. Ericsson, B. Johansson-Lindbom, M. Svensson, J. Marsal, M. Mack, D. Picarella, D. Soler, G. Marquez, M. Briskin, et al.
Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine
Blood,
May 1, 2006;
107(9):
3447 - 3454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Chen, N. Zhang, S. Fu, B. Schroppel, Q. Guo, A. Garin, S. A. Lira, and J. S. Bromberg
CD4+CD25+ Regulatory T-Cells Inhibit the Islet Innate Immune Response and Promote Islet Engraftment.
Diabetes,
April 1, 2006;
55(4):
1011 - 1021.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Duplan, G. Beriou, J.-M. Heslan, C. Bruand, P. Dutartre, L. T. Mars, R. S. Liblau, M.-C. Cuturi, and A. Saoudi
LF 15-0195 Treatment Protects against Central Nervous System Autoimmunity by Favoring the Development of Foxp3-Expressing Regulatory CD4 T Cells
J. Immunol.,
January 15, 2006;
176(2):
839 - 847.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
